XTX Topco’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

XTX Topco’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,020	Closed	-$47.9K	–	2737
2024 Q2	$47.9K	Buy	21,020 +10,718	+104%	+$40.9K	﹤0.01%	1516
2024 Q1	$44.5K	Sell	10,302 -146,899	-93%	-$512K	0.01%	1486
2023 Q4	$479K	Sell	157,201 -139,400	-47%	-$262K	0.11%	286
2023 Q3	$427K	Buy	296,601 +186,753	+170%	+$361K	0.07%	490
2023 Q2	$274K	Sell	109,848 -184,444	-63%	-$504K	0.05%	782
2023 Q1	$789K	Buy	294,292 +192,010	+188%	+$923K	0.17%	99
2022 Q4	$555K	Buy	102,282 +87,345	+585%	+$732K	0.12%	255
2022 Q3	$187K	Sell	14,937 -30,619	-67%	-$350K	0.05%	806
2022 Q2	$225K	Buy	+45,556	New	+$252K	0.09%	419

XTX Topco's GTHX Position: Q3 2024 in Review

XTX Topco sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 21,020 shares — an estimated $47.9K sold.

XTX Topco first reported a position in GTHX in Q2 2022 and held it in 9 quarters. The position peaked at $789K in Q1 2023. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

XTX Topco reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
XTX Topco sold 21,020 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $47.9K.
XTX Topco first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2022 and held it in 9 quarters.
XTX Topco's G1 Therapeutics, Inc. Common Stock position peaked at $789K in Q1 2023.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.